India's Pharma Market Hits $50 Billion, 3rd Globally in FY 2023-24

India's pharmaceutical sector, ranked as the third largest in the world by volume, was valued at $50 billion in the fiscal year 2023-24, as per Union Minister of State for Chemicals and Fertilizers Anupriya Patel. The domestic consumption value of...

Chronic Diseases Fuel Surge in Biologics CDMO Secondary Packaging Market

The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...

US FDA Approves Merck'sBLA for Clesrovimab to Protect Infants from RSV

Merck announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for clesrovimab (MK-1654), the company's experimental long-acting monoclonal antibody aimed at safeguarding infants from...

Supriya Lifescience Expands Production to Strengthen Market Position

Supriya Lifescience's new plant is anticipated to improve production capabilities, aiding its expansion in the competitive pharmaceutical sector. Pharma shares experienced a 6 percent rise after the launch of a modern E-Production Block in...

Clinical Trials Embrace AI to Tackle Failures and Enhance Drug Predictions

The market for AI in clinical trials is fueled by the significant rate of clinical trial failures, the growing demand for predicting drug pharmacokinetics, pharmacodynamics, and toxicity management. The worldwide market for artificial intelligence...

USFDA Clears Smith+Nephew's Stemless Shoulder Implant for AETOS System

Smith+Nephew, the worldwide medical technology firm, announces it has obtained 510(k) authorization from the United States Food & Drug Administration for a stemless anatomical total shoulder for the AETOS Shoulder System (AETOS Stemless). AETOS...

China to Lead Pharma Data Analytics Market with 25.9% Share by 2028

China is the biggest market for data and analytics in the pharmaceutical industry, accounting for about 20.2% of worldwide sales in 2022, rising to 25.9% by 2028. The global data and analytics market in pharmaceuticals is projected to grow at a...

PLI Scheme Boosts Drug Security and Domestic Production

The PLI scheme will enhance resilience against external shocks, strengthen drug security, and increase the ability to produce critical bulk drugs and higher-value products domestically. The three support schemes revealed by the government will...

USFDA Grants Tentative Approval for Lasix ONYU in Heart Failure Treatment

Gerresheimer, a creative systems and solutions provider and a worldwide partner for the pharmaceutical, biotech, and cosmetics sectors, has announced that the US Food and Drug Administration (FDA) has granted SQ Innovation Tentative Approval for...

Strategic Pricing Drives Indian Pharma Market to Rs 19,388 Crore Growth

The Indian Pharmaceutical Market experienced significant growth, reaching Rs 19,388 crore in November 2024. Strategic pricing played a crucial role in this increase, as several therapies saw price rises. Chronic therapy areas, especially cardiac...

© 2025 India Pharma Outlook. All Rights Reserved.